Lenmeldy 83222-0200
Generic: Atidarsagene Autotemcel
Product NDC
83222-0200- Manufacturer
- Orchard Therapeutics (europe) Ltd
- Dosage Form
- Suspension
- Route
- Intravenous
- Product Type
- Cellular Therapy
- Marketing Start
- April 26, 2024
- Listing Expires
- December 31, 2026
- Application
- BLA125758
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atidarsagene Autotemcel | 11800000 1/1 |
Packaging Options(1)
1 SUSPENSION in 1 BAG (83222-0200-1)